Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study.

Marcelo Maia Pinheiro,Felipe Moura Maia Pinheiro, Marcelo Müller de Arruda, Geane Moron Beato, Graciele Alves Corrêa Lima Verde, Georgiana Bianchini,Pedro Rosário Moraes Casalenuovo, Aline Aparecida Agostini Argolo,Lucilene Telles de Souza, Flávia Gomes Pessoa, Thiago Santos Hirose,Eduardo Filgueiras Senra,Camillo Ricordi,Andrea Fabbri,Marco Infante,Susana Nogueira Diniz

Archives of endocrinology and metabolism（2023）

Cited 2|Views10

No score

Abstract

Therapy with VIDPP-4i was associated with a higher frequency and duration of the honeymoon phase. Randomized controlled trials are needed to confirm these findings.

Translated text

Key words

vitamin d3,diabetes,sitagliptin,clinical remission,new-onset,case-control

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined